Highlights from International Conference on Cancer Health Disparities 2021.

Research symposium cancer biology cancer health disparities drug delivery medical research

Journal

Cancer health disparities
ISSN: 2573-9530
Titre abrégé: Cancer Health Disparities
Pays: United States
ID NLM: 101728460

Informations de publication

Date de publication:
2022
Historique:
medline: 1 1 2022
pubmed: 1 1 2022
entrez: 24 5 2023
Statut: ppublish

Résumé

The first International Conference on Cancer Health Disparities (ICCHD) was held on August 13-14, 2021, in Harlingen, TX, USA. This two-day ICCHD-2021 was organized by the University of Texas Rio Grande Valley, School of Medicine (UTRGV-SOM). About 200 national and international delegates from 10 countries attended this hybrid meeting in person and through online digital platforms. The event delegates were representatives from National Institutes of Health (NIH), Cancer Prevention and Research Institute of Texas (CPRIT), and the City of Harlingen, in addition to clinicians, faculty, researchers, scientists, bioinformaticians, geneticists, bioethicists, and others. Under the theme of Cancer Health Disparities, this event featured a number of special talks and showcased the work done by researchers from a broad array of disciplines (academia, community, and health care) to identify gaps and/or solutions to multi-faceted heath and health disparity issues impacting minority and underserved populations across the country and worldwide. The conference was comprised of six sessions: Session 1: Introduction to the conference and tackling cancer health disparities; Session 2: Elimination of cancer health disparities; Session 3: Cancer cellular and molecular biology; Session 4: Diversity and Inclusion in cancer research: Session 5: Poster and oral presentations, and Early career investigator talks; Session 6: An award ceremony and closing remarks. This conference report summarizes the meeting's content, discussions, and conclusions.

Identifiants

pubmed: 37223259
pmc: PMC10205099
mid: NIHMS1849069
pii:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R13 CA254453
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of interest The authors have no conflicts of interest to report.

Références

Transdiscipl J Eng Sci. 2016;7:
pubmed: 30792830

Auteurs

Murali M Yallapu (MM)

Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.

Jorge Teniente (J)

Office of Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.

Andrew Tsin (A)

Office of Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
Department of Molecular Sciences, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.

Subhash C Chauhan (SC)

Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.

Classifications MeSH